<DOC>
	<DOCNO>NCT01240980</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability effect blood glucose control BMS-903452 compare placebo healthy subject &amp; relative bioavailability crystalline amorphous form BMS-903452 [ Panels 4,6,11 &amp; 12 ( Part A ) ] ; subject type 2 Diabetes Mellitus ( Part B ) . The study also determine amount BMS-903452 blood .</brief_summary>
	<brief_title>Safety Study BMS-903452 Healthy Subjects ( Panel 1-7 ) &amp; Relative Bioavailability Crystalline Amorphous Forms BMS-903452 Panels 4 , 6 , 11 &amp; 12 ( Part A ) , Subjects With Type 2 Diabetes Mellitus ( Part B )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Clinically healthy Clinical diagnosis Type 2 diabetes stable dose metformin monotherapy Type 1 Diabetes History significant heart disease Prior bariatric surgery Women childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>